Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
September 19, 2022
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
European Medicines Agency
Eurasia
RHHBF
From
Benzinga
WHO Recommends Against Roche, GSK's COVID-19 Therapies Rendering Them Obsolete
September 16, 2022
Tickers
GSK
REGN
RHHBF
RHHBY
Tags
RHHVF
General
RHHBF
From
Benzinga
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
September 13, 2022
Tickers
NVS
OTLK
REGN
RHHBY
Tags
Long Ideas
REGN
Price Target
From
Benzinga
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know
September 12, 2022
Tickers
ABML
ADDYY
BASFY
BFFAF
Tags
BASFY
NGLOY
NWBO
From
Benzinga
Why Regeneron Pharmaceuticals Stock Is Crushing It Today
September 08, 2022
Tickers
BAYN
REGN
RHHBY
Tags
REGN
RHHBY
Recent Press Releases
From
Motley Fool
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
Tickers
A
ABT
BDX
BRKR
Tags
QGEN
Top Stories
BRKR
From
Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
August 25, 2022
Tickers
ESALF
ESALY
LLY
RHHBF
Tags
Biotech
Benzinga
ESALY
From
Benzinga
China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche's Genentech
August 18, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
News
Large Cap
From
Benzinga
Roche's Polivy Combo Regime Under FDA Review For Type Of Blood Cancer
August 16, 2022
Tickers
RHHBF
RHHBY
RHHVF
SGEN
Tags
RHHBY
Market News
News
From
Benzinga
OTC Markets' Most Active Securities Sees A Shake-up In July
August 16, 2022
Tickers
ADDYY
AYRWF
BASFY
BMIX
Tags
IFNNY
ADDYY
ETHE
From
Benzinga
FDA Approves Expanded Use Of Roche's Influenza Treatment
August 12, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Large Cap
News
From
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Tickers
ADMP
AEMD
ALPN
ARDS
Tags
Offerings
ADMP
Health Care
From
Benzinga
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
August 08, 2022
Tickers
AMGN
MRK
RHHBF
RHHBY
Tags
Briefs
Benzinga
Biotech
From
Benzinga
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month
August 05, 2022
Tickers
ADDYY
BASFY
BNPQY
BTC
Tags
ETH
NKE
UA
From
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
News
CHRS
Penny Stocks
From
Benzinga
Kiniksa Inks Global License Agreement With Roche For Vixarelimab
August 03, 2022
Tickers
KNSA
RHHBY
Tags
Briefs
Benzinga
Biotech
From
Benzinga
Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field
August 03, 2022
Tickers
PSTX
RHHBF
RHHBY
RHHVF
Tags
Health Care
Trading Ideas
Penny Stocks
From
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Tickers
ABBV
ACIU
ALLR
AXLA
Tags
ACIU
General
Small Cap
From
Benzinga
How This Multibillion-Dollar Company Is Shaking Off the Competition
July 30, 2022
Tickers
CHGCY
REGN
RHHBY
Tags
Market News
Recent Press Releases
CHGCY
From
Motley Fool
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Tickers
ABBV
ADMP
ARQT
AZN
Tags
IBB
FDA
Legal
From
Benzinga
Why Shares of Agenus Inc. Rose 10.1% on Tuesday
July 26, 2022
Tickers
AGEN
RHHBY
Tags
RHHBY
Market News
AGEN
From
Motley Fool
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product
July 25, 2022
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
RHHVF
General
RHHBF
From
Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
July 21, 2022
Tickers
ABBV
ABUS
ASMB
HLVX
Tags
IBB
FDA
RHHBF
From
Benzinga
Benzinga Before The Bell: Baidu Beats Tesla, Finland Sells $47.5M Bitcoins, Tesla's Bitcoin Sale And Other Top Financial Stories Thursday, July 21
July 21, 2022
Tickers
AAPL
AMZN
BIDU
BIIB
Tags
$ETH
BIIB
RHHBY
From
Benzinga
Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit
July 21, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Management
RHHBF
RHHVF
From
Benzinga
Novartis Posts Mixed Q2 Earnings, Expects Improved Earnings At Sandoz
July 19, 2022
Tickers
NVS
RHHBY
Tags
RHHBY
why it's moving
Market News
From
Benzinga
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
July 18, 2022
Tickers
ADDYY
AERG
AXAHY
BNPQY
Tags
Market News
Markets
AXAHY
From
Benzinga
Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test
July 18, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
Health Care
From
Benzinga
New Data Reinforce Favorable Safety, Efficacy Of Roche's Hemlibra For Hemophilia A
July 11, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Large Cap
News
Health Care
From
Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After
July 11, 2022
Tickers
BIOVF
CANF
IBB
INVA
Tags
Biotech
Benzinga
IONS
From
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.